LFP | A1 | 45 (4.0) | 29 (1.93) | 111 (16.86) | Trial averaged |
LB | 58 (6.76) | 45 (5.65) | 121 (13.77) | (t test on raw data) |
Spike | A1 | 87 (10.36) | 63 (5.47) | 140 (15.55) | |
| LB | 103 (13.11) | 83 (8.86) | 164 (26.15) | |
| | PT (56)
| Coo (56)
| PT-Coo (56)
| |
LFP | A1 | 60 (7.13) | 51 (5.8) | 155 (22.57) | Trial averaged |
LB | 57 (5.59) | 55 (7.37) | 170 (22.19) | (t test on AccLLR) |
Spike | A1 | 67 (10.54) | 74 (6.15) | 89 (16.54) | |
| LB | 87 (11.76) | 94 (11.43) | 106 (20.91) | |
| | PT (15319)
| Coo (15326)
| PT (13825)
| Coo (14035)
| |
LFP | A1 | 35 (0.22) | 31 (0.21) | 113 (1.04) | 111 (1.03) | AccLLR: trial-by-trial |
LB | 36 (0.32) | 39 (0.29) | 161 (1.38) | 167 (1.48) | |
Spike | A1 | 52 (0.40) | 69 (0.46) | 187 (1.64) | 178 (1.77) | |
| LB | 92 (0.56) | 66 (0.33) | 163 (1.67) | 155 (1.77) | |
LFP
| A1 | 38 (3.4) | 26 (2.7) | 62 (3.1) | 58 (2.32) | AccLLR: 100% accuracy matched pooled trials |
LB | 30 (3.06) | 31 (2.9) | 90 (8.0) | 84 (7.15) | |
Spike
| A1 | 39 (3.4) | 48 (4.45) | 69 (5.48) | 75 (7.5) | |
LB | 49 (5.3) | 41 (4.3) | 83 (8.02) | 78 (7.33) | |